{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:48:04Z","timestamp":1768690084957,"version":"3.49.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,28]]},"abstract":"<jats:p>We aimed to determine the performance of the 2017 European League Against Rheumatism\/American College of Rheumatology (EULAR\/ACR) classification criteria for idiopathic inflammatory myopathies (IIMs) in a cohort of Chilean patients. This single-center retrospective study included 151 patients with a clinical diagnosis of IIM. Patients were classified according to the 2017 EULAR\/ACR classification criteria for IIM, and its performance was compared to the Bohan &amp; Peter (B&amp;P) classification criteria. A total of 135 patients (89.4%) met the EULAR\/ACR criteria, and 140 (92.7%) patients met the B&amp;P criteria. A total of 130 patients had IIM according to both the criteria; concordance rate was 29.2% for definite IIM, 6.2% for probable IIM, and 1.5% for possible IIM. The kappa coefficient of agreement was weak between the 2 classification criteria (\u03ba = 0.39, SD 0.15\u20130.64). Against gold standard expert physician\u2019s diagnosis, sensitivity, and specificity of EULAR\/ACR criteria was 0.86 and 0.85 to diagnose dermatomyositis, respectively, and 0.73 and 0.87 to diagnose polymyositis. The EULAR\/ACR criteria showed good sensitivity and identified more patients with probable or definite IIM than the B&amp;P criteria in a single-center cohort of patients with IIM in South America. The sensitivity of the EULAR\/ACR criteria was slightly higher in patients with dermatomyositis, but lower in patients with polymyositis, than that of the B&amp;P criteria.<\/jats:p>","DOI":"10.1097\/md.0000000000031015","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T03:01:03Z","timestamp":1667185263000},"page":"e31015","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Performance of the 2017 EULAR\/ACR criteria for idiopathic inflammatory myopathies in a cohort of patients from Latin America"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3357-9402","authenticated-orcid":false,"given":"Antonia","family":"Valenzuela","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Pontificia Universidad Cat\u00f3lica de Chile, Santiago de Chile, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Torres","sequence":"additional","affiliation":[{"name":"School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago de Chile, Chile."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Domingo","family":"Dev\u00e9s","sequence":"additional","affiliation":[{"name":"School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago de Chile, Chile."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases.","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s10067-019-04512-6","article-title":"Comparison of the 2017 EULAR\/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.","volume":"38","author":"Pinto","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e000507","DOI":"10.1136\/rmdopen-2017-000507","article-title":"EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.","volume":"3","author":"Bottai","year":"2017","journal-title":"RMD Open"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.semarthrit.2019.12.001","article-title":"Performance of the new EULAR\/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.","volume":"50","author":"Barsotti","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/1756-185X.13605","article-title":"Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR\/ACR in Chinese patients.","volume":"22","author":"Zhang","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/annrheumdis-2019-215488","article-title":"First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)\/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.","volume":"79","author":"Jinnin","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.41964","article-title":"Performance of the 2017 EULAR\/ACR classification criteria for inflammatory myopathies in patients with myositis-specific autoantibodies.","volume":"74","author":"Casal-Dominguez","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1136\/annrheumdis-2019-215515","article-title":"Response to: \u201cComment on: \u2018Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria\u2019 by Greco et al\u201d by Knitza et al.","volume":"79","author":"Tj\u00e4rnlund","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1093\/rheumatology\/keaa801","article-title":"Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.","volume":"60","author":"Loarce-Martos","year":"2021","journal-title":"Rheumatology (Oxford)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:33:57Z","timestamp":1746333237000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":13,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031015","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,28]]}}}